Neutralizing antibodies (NABS) and interferon beta-1B therapy of multiple sclerosis

被引：0

作者：

Horowski, R ^{[1
]}

Stürzebecker, CS ^{[1
]}

Kapp, JF ^{[1
]}

机构：

[1] Schering AG, SBU Therapeut, D-13342 Berlin, Germany

来源：

关键词：

beta-interferons; multiple sclerosis; neutralizing antibodies;

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：117 / 128

页数：12

共 44 条

[1] AbdulAhad AK, 1997, CYTOKINES CELL MOL T, V3, P27
[2] Antonelli G, 1999, EUR CYTOKINE NETW, V10, P413
[3] Arnason Barry G., 1998, Journal of Interferon and Cytokine Research, V18, P639, DOI 10.1089/jir.1998.18.639
[4] Mechanisms of action of interferon-beta in multiple sclerosis
Arnason, BGW
Dayal, A
Qu, ZX
Jensen, MA
Genc, K
Reder, AT
[J]. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1996, 18 (01): : 125 - 148
[5] ARNASON BGW, 1997, INT MS J, V2, P40
[6] INTERFERONS IN MULTIPLE-SCLEROSIS - WARNINGS FROM EXPERIENCES
BILLIAU, A
[J]. NEUROLOGY, 1995, 45 (06) : S50 - S53
[7] BLUMHARDT L, 1999, LECT JOINT ECTRIMS A
[8] Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b
Calabresi, PA
Tranquill, LR
Dambrosia, JM
Stone, LA
Maloni, H
Bash, CN
Frank, JA
McFarland, HF
[J]. ANNALS OF NEUROLOGY, 1997, 41 (05) : 669 - 674
[9] Calabresi PA, 1997, NEUROLOGY, V48, P5004
[10] PHARMACOKINETICS OF RECOMBINANT HUMAN INTERFERON-BETA(SER) IN HEALTHY-VOLUNTEERS AND ITS EFFECT ON SERUM NEOPTERIN
CHIANG, J
GLOFF, CA
YOSHIZAWA, CN
WILLIAMS, GJ
[J]. PHARMACEUTICAL RESEARCH, 1993, 10 (04) : 567 - 572